Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPOS vs GnRH Antagonist in IVF
NCT06396390Phase 4Not yet recruiting
- Start
- Aug 2024
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dydrogesterone in infertility (2 arms). Primary endpoint: Blastulation Rate at Day 6. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
dydrogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06396390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06396390.